EX-2.1
from 8-K
2 pages
Amendment No. 1, Dated as of April 4, 2011 (This “Amendment”), to the Merger Agreement Referred to Below, Among Fl Holding CV, an Entity Organized Under the Laws of the Netherlands (“Parent”), Magnolia Acquisition Corp., a Delaware Corporation and an Indirect Wholly Owned Subsidiary of Parent (“Purchaser”), Forest Laboratories, Inc., a Delaware Corporation and the Indirect Parent of Parent (The “Guarantor”) and Clinical Data, Inc., a Delaware Corporation (The “Company”)
12/34/56
EX-2.1
from DEFA14A
2 pages
Amendment No. 1, Dated as of April 4, 2011 (This “Amendment”), to the Merger Agreement Referred to Below, Among Fl Holding CV, an Entity Organized Under the Laws of the Netherlands (“Parent”), Magnolia Acquisition Corp., a Delaware Corporation and an Indirect Wholly Owned Subsidiary of Parent (“Purchaser”), Forest Laboratories, Inc., a Delaware Corporation and the Indirect Parent of Parent (The “Guarantor”) and Clinical Data, Inc., a Delaware Corporation (The “Company”)
12/34/56
EX-2.1
from 8-K
37 pages
Asset Purchase Agreement by and Among Avalon Pharmaceuticals, Inc., as “Seller”, Clinical Data, Inc., as “Seller Parent”, Pgxhealth, LLC, as “Seller Affiliate” and Intrexon Corporation as “Buyer”
12/34/56
EX-2.1
from 8-K/A
76 pages
Stock Purchase Agreement by and Among Clinical Data, Inc., a Delaware Corporation, Clinical Data B.V., a Company Registered Under the Laws of the Netherlands, Beckman Coulter, Inc., a Delaware Corporation Beckman Coulter Gmbh, a Company Registered Under the Laws of the Republic of Germany Beckman Coulter Holdings Gmbh a Company Registered Under the Laws of the Republic of Germany Dated as of April 1, 2009
12/34/56
EX-2.1
from 425
76 pages
Stock Purchase Agreement by and Among Clinical Data, Inc., a Delaware Corporation, Clinical Data B.V., a Company Registered Under the Laws of the Netherlands, Beckman Coulter, Inc., a Delaware Corporation Beckman Coulter Gmbh, a Company Registered Under the Laws of the Republic of Germany Beckman Coulter Holdings Gmbh a Company Registered Under the Laws of the Republic of Germany Dated as of April 1, 2009
12/34/56
EX-2
from 8-K
~5
pages
Amendment Dated as of April 29, 2003 to Asset Purchase Agreement Dated as of December 9, 2002 (As Amended) by and Among Elan Pharmaceuticals, Inc., Elan Diagnostics, Inc., Novitron International, Inc. and Clinical Data Inc. Amendment
12/34/56